Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 15.3.2021 | EN | Official Journal of the European Union | C 88/28 |

---

Judgment of the General Court of 27 January 2021 — Olimp Laboratories v EUIPO — OmniVision (Hydrovision)

(Case T-817/19) [(1)](#ntr1-C_2021088EN.01002801-E0001)

(EU trade mark - Opposition proceedings - Application for EU figurative mark Hydrovision - Earlier EU word mark Hylo-Vision - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

(2021/C 88/36)

Language of the case: English

Parties

Applicant: Olimp Laboratories sp. z o.o. (Dębica, Poland) (represented by: M. Kondrat, lawyer)

Defendant: European Union Intellectual Property Office (represented by: D. Walicka, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: OmniVision GmbH (Puchheim, Germany) (represented by: B. Sorg, D. Wiedemann and M. Ringer, lawyers)

Re:

Action brought against the decision of the Second Board of Appeal of EUIPO of 13 September 2019 (Case R 2371/2018 2), relating to opposition proceedings between OmniVision and Olimp Laboratories.

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Dismisses the action; |

|  |  |
| --- | --- |
| 2. | Orders Olimp Laboratories sp z o.o. to pay the costs. |

---

---

[Top](#document1)